Pfizer's CEO said the company could make 'tremendous investments' in the US if Trump's tariffs go away

  • Pfizer's CEO said tariff uncertainty is hindering the company from making big investments in the US. Albery Bourla said there could be "tremendous investments" in R&D and manufacturing in the US.